Autolus Ltd.

About Autolus Ltd.

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.

Website	http://www.autolus.com
Employees	201-500 employees View all Autolus Ltd. employees
Industry	Biotechnology
Location	Autolus Limited, London, GB
Founded	2014